TrustCore Financial Services’s Harvard Bioscience HBIO Stock Holding History

TrustCore Financial Services’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.66K	Hold	60	–	–	﹤0.01%	912
2022 Q3	$2K	Hold	60	–	–	﹤0.01%	960
2022 Q2	$2K	Hold	60	–	–	﹤0.01%	946
2022 Q1	$4K	Buy	+60	New	+$3.55K	﹤0.01%	889
2021 Q4	–	Sell	-60	Closed	-$4K	–	989
2021 Q3	$4K	Hold	60	–	–	﹤0.01%	890
2021 Q2	$5K	Hold	60	–	–	﹤0.01%	840
2021 Q1	$3K	Hold	60	–	–	﹤0.01%	841
2020 Q4	$3K	Hold	60	–	–	﹤0.01%	813
2020 Q3	$2K	Hold	60	–	–	﹤0.01%	769
2020 Q2	$2K	Hold	60	–	–	﹤0.01%	802
2020 Q1	$1K	Hold	60	–	–	﹤0.01%	824
2019 Q4	$2K	Hold	60	–	–	﹤0.01%	824
2019 Q3	$2K	Hold	60	–	–	﹤0.01%	859
2019 Q2	$1K	Hold	60	–	–	﹤0.01%	869
2019 Q1	$3K	Buy	+60	New	+$2.17K	﹤0.01%	732
2018 Q4	–	Sell	-60	Closed	-$3K	–	562
2018 Q3	$3K	Buy	+60	New	+$3.37K	﹤0.01%	726

Other funds holding HBIO

272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return

Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MIM

Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

TrustCore Financial Services's HBIO Position: Q4 2022 in Review

TrustCore Financial Services held its Harvard Bioscience (HBIO) position steady in Q4 2022 at 60 shares worth $1.66K. The position accounts for ﹤0.01% of the portfolio, ranked #912.

TrustCore Financial Services first reported a position in HBIO in Q3 2018 and has held it in 16 quarters since. The position peaked at $5K in Q2 2021. 68 funds tracked by Wall St. Rank hold HBIO as of Q4 2022.

TrustCore Financial Services held 60 shares of Harvard Bioscience worth $1.66K as of Q4 2022.
TrustCore Financial Services left its Harvard Bioscience share count unchanged in Q4 2022.
Harvard Bioscience made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #912 holding.
TrustCore Financial Services first reported a position in Harvard Bioscience in Q3 2018 and has held it in 16 quarters since.
TrustCore Financial Services's Harvard Bioscience position peaked at $5K in Q2 2021.
68 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.